{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T10:31:38Z","timestamp":1780741898848,"version":"3.54.1"},"reference-count":23,"publisher":"Japan Neurosurgical Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol. Med. Chir.(Tokyo)"],"published-print":{"date-parts":[[2015]]},"DOI":"10.2176\/nmc.ra.2014-0307","type":"journal-article","created":{"date-parts":[[2015,2,19]],"date-time":"2015-02-19T22:07:10Z","timestamp":1424383630000},"page":"189-193","source":"Crossref","is-referenced-by-count":113,"title":["Diagnosis of Moyamoya Disease: International Standard and Regional Differences"],"prefix":"10.2176","volume":"55","author":[{"given":"Miki","family":"FUJIMURA","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teiji","family":"TOMINAGA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Suzuki J, Takaku A: Cerebrovascular \u201cmoyamoya\u201d disease. Disease showing abnormal net-like vessels in base of brain. <i>Arch Neurol<\/i> 20: 288\u2013299, 1969","DOI":"10.1001\/archneur.1969.00480090076012"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases: Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). <i>Neurol Med Chir (Tokyo)<\/i> 52: 245\u2013266, 2012","DOI":"10.2176\/nmc.52.245"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Fukui M: Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (\u2018moyamoya\u2019 disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. <i>Clin Neurol Neurosurg<\/i> 99(Suppl 2): S238\u2013S240, 1997","DOI":"10.1016\/S0303-8467(97)00082-6"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Smith ER, Scott RM: Spontaneous occlusion of the circle of Willis in children: pediatric moyamoya summary with proposed evidence-based practice guidelines. A review. <i>J Neurosurg Pediatr<\/i> 9: 353\u2013360, 2012","DOI":"10.3171\/2011.12.PEDS1172"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kleinloog R, Regli L, Rinkel GJ, Klijn CJ: Regional differences in incidence and patient characteristics of moyamoya disease: a systematic review. <i>J Neurol Neurosurg Psychiatr<\/i> 83: 531\u2013536, 2012","DOI":"10.1136\/jnnp-2011-301387"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kim JE, Jeon JS: An update on the diagnosis and treatment of adult Moyamoya disease taking into consideration controversial issues. <i>Neurol Res<\/i> 36: 407\u2013416, 2014","DOI":"10.1179\/1743132814Y.0000000351"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Hayashi K, Horie N, Izumo T, Nagata I: Nationwide survey on quasi-moyamoya disease in Japan. <i>Acta Neurochir (Wien)<\/i> 156: 935\u2013940, 2014","DOI":"10.1007\/s00701-014-2013-0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) S\u00e9bire G, Fullerton H, Riou E, de Veber G: Toward the definition of cerebral arteriopathies of childhood. <i>Curr Opin Pediatr<\/i> 16: 617\u2013622, 2004","DOI":"10.1097\/01.mop.0000144441.29899.20"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Ganesan V: Moyamoya: to cut or not to cut is not the only question. A paediatric neurologist\u2019s perspective. <i>Dev Med Child Neurol<\/i> 52: 10\u201313, 2010","DOI":"10.1111\/j.1469-8749.2009.03527.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Shimoda Y, Fujimura M, Inoue T, Shimizu H, Tominaga T: Temporal profile of de novo development of moyamoya vasculopathy in an adult: case report. <i>Neurol Med Chir (Tokyo)<\/i> 52: 339\u2013342, 2012","DOI":"10.2176\/nmc.52.339"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Akamatsu Y, Fujimura M, Uenohara H, Shimizu H, Tominaga T: Development of moyamoya disease in pregnancy and puerperium\u2014case report. <i>Neurol Med Chir (Tokyo)<\/i>, 2014 [Epub ahead of print]","DOI":"10.2176\/nmc.cr.2014-0071"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Fujimura M, Tominaga T: Lessons learned from moyamoya disease: outcome of direct\/indirect revascularization surgery for 150 affected hemispheres. <i>Neurol Med Chir (Tokyo)<\/i> 52: 327\u2013332, 2012","DOI":"10.2176\/nmc.52.327"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Oka K, Yamashita M, Sadoshima S, Tanaka K: Cerebral haemorrhage in Moyamoya disease at autopsy. <i>Virchows Arch A Pathol Anat Histol<\/i> 392: 247\u2013261, 1981","DOI":"10.1007\/BF02155663"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Takagi Y, Kikuta K, Nozaki K, Hashimoto N: Histological features of middle cerebral arteries from patients treated for Moyamoya disease. <i>Neurol Med Chir (Tokyo)<\/i> 47: 1\u20134, 2007","DOI":"10.2176\/nmc.47.1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, Kanno J, Niihori T, Ono M, Ishii N, Owada Y, Fujimura M, Mashimo Y, Suzuki Y, Hata A, Tsuchiya S, Tominaga T, Matsubara Y, Kure S: A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. <i>J Hum Genet<\/i> 56: 34\u201340, 2011","DOI":"10.1038\/jhg.2010.132"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda A, Kikuta K, Takagi Y, Harada KH, Fujiyama A, Herzig R, Krischek B, Zou L, Kim JE, Kitakaze M, Miyamoto S, Nagata K, Hashimoto N, Koizumi A: Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. <i>PLoS ONE<\/i> 6: e22542, 2011","DOI":"10.1371\/journal.pone.0022542"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, Tsurusaki Y, Doi H, Sakai H, Saitsu H, Shimojima K, Yamamoto T, Higurashi M, Kawahara N, Kawauchi H, Nagasaka K, Okamoto N, Mori T, Koyano S, Kuroiwa Y, Taguri M, Morita S, Matsubara Y, Kure S, Matsumoto N: Homozygous c.14576G&gt;A variant of RNF213 predicts early-onset and severe form of moyamoya disease. <i>Neurology<\/i> 78: 803\u2013810, 2012","DOI":"10.1212\/WNL.0b013e318249f71f"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Sonobe S, Fujimura M, Niizuma K, Nishijima Y, Ito A, Shimizu H, Kikuchi A, Arai-Ichinoi N, Kure S, Tominaga T: Temporal profile of the vascular anatomy evaluated by 9.4-tesla magnetic resonance angiography and histopathological analysis in mice lacking RNF213; a susceptibility gene for moyamoya disease. <i>Brain Res<\/i> 1552: 64\u201367, 2014","DOI":"10.1016\/j.brainres.2014.01.011"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Wei YC, Liu CH, Chang TY, Chin SC, Chang CH, Huang KL, Chang YJ, Peng TI, Lee TH: Coexisting diseases of moyamoya vasculopathy. <i>J Stroke Cerebrovasc Dis<\/i> 23: 1344\u20131350, 2014","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.11.008"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Kim SJ, Heo KG, Shin HY, Bang OY, Kim GM, Chung CS, Kim KH, Jeon P, Kim JS, Hong SC, Lee KH: Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study. <i>Stroke<\/i> 41: 173\u2013176, 2010","DOI":"10.1161\/STROKEAHA.109.562264"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Li H, Zhang ZS, Dong ZN, Ma MJ, Yang WZ, Han C, Du MM, Liu YX, Yang H, Liu W, Duan L, Cao WC: Increased thyroid function and elevated thyroid autoantibodies in pediatric patients with moyamoya disease: a case-control study. <i>Stroke<\/i> 42: 1138\u20131139, 2011","DOI":"10.1161\/STROKEAHA.110.608471"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Bower RS, Mallory GW, Nwojo M, Kudva YC, Flemming KD, Meyer FB: Moyamoya disease in a primarily white, midwestern US population: increased prevalence of autoimmune disease. <i>Stroke<\/i> 44: 1997\u20131999, 2013","DOI":"10.1161\/STROKEAHA.111.000307"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Mallory GW, Bower RS, Nwojo ME, Taussky P, Wetjen NM, Varzoni TC, Hanel RA, Meyer FB: Surgical outcomes and predictors of stroke in a North American white and African American moyamoya population. <i>Neurosurgery<\/i> 73: 984\u2013991; discussion 981\u2013982, 2013","DOI":"10.1227\/NEU.0000000000000162"}],"container-title":["Neurologia medico-chirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/55\/3\/55_ra.2014-0307\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T03:08:08Z","timestamp":1566356888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/55\/3\/55_ra.2014-0307\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2176\/nmc.ra.2014-0307","relation":{},"ISSN":["0470-8105","1349-8029"],"issn-type":[{"value":"0470-8105","type":"print"},{"value":"1349-8029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}